Enteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.
J Pediatr Pharmacol Ther
; 19(4): 317-24, 2014.
Article
en En
| MEDLINE
| ID: mdl-25762878
We describe the use of topiramate in a healthy 12-year-old (88-kg) male who developed refractory generalized convulsive status epilepticus. Seizures persisted despite aggressive use of benzodiazepines (intravenous lorazepam; oral clorazepate), barbiturates (i.e., phenobarbital, pentobarbital), and hydantoins. The child's seizures were controlled with nasogastrically administered topiramate in doses up to 500 mg twice daily (11.4 mg/kg/day). The patient did not display any clinical or laboratory signs of metabolic acidosis while receiving topiramate. Topiramate should be considered as a treatment option in refractory status epilepticus.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
J Pediatr Pharmacol Ther
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Estados Unidos